On April 20, 2018, the deputy director of the China Securities Regulatory Commission Shang Qingjun etc. visited Olymvax. Mr. Hu Cheng, vice chairman of Olymvax, and Ms. Fan Fan, board member of the company, and the management team attended the reception.
Mr. Hu Cheng,Vice Chairman of the Board of Directors, briefed the leaders of the Securities Regulatory Commission the development strategy of independent research and innovative progress in core technologies. Mr.Wu Wei, the secretary of the board of directors, made a brief report to the visitors of the company general profile.
After the meeting, the visitors visited the production workshop accompanied by company directors and senior executives. Encouraged, Olymvax will stick to its strategy and make more contribution in the future.